News and Trends 17 Oct 2022
Italian study shows CRISPR/Cas9 deletion of Interleukin-30 reduces prostate cancer growth
…by CRISPR/Cas9 genome editing, on tumor growth. Bioinformatics of transcriptional data and immunopathology of prostate cancer samples were used to assess the translational value of the experimental findings. Results Human…